Sahin, T. K. Et Al. 2024. Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy. International Journal of Clinical Oncology .

Sahin, T. K., ÖZBAY, Y., ALTUNBULAK, A. Y., ALTUNBULAK, H. İ., ONUR, M. R., Ceylan, F., ... GÜVEN, D. C.(2024). Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy. International Journal of Clinical Oncology .

Sahin, TAHA Et Al. "Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy," International Journal of Clinical Oncology , 2024

Sahin, TAHA K. Et Al. "Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy." International Journal of Clinical Oncology , 2024

Sahin, T. K. Et Al. (2024) . "Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy." International Journal of Clinical Oncology .

@article{article, author={TAHA KORAY ŞAHİN Et Al. }, title={Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy}, journal={International Journal of Clinical Oncology}, year=2024}